This conference call transcript was computer generated and almost certianly contains errors. This transcript is provided for information purposes only.EarningsCall, LLC makes no representation about the accuracy of the aforementioned transcript, and you are cautioned not to place undue reliance on the information provided by the transcript.
2/28/2025
Operator
Conference Call Operator
gentlemen. Thank you for standing by and welcome to the Appellate Pharmaceuticals fourth quarter and full year 2024 earnings conference call. At this time, all participants are in a listen-only mode. After the speaker's presentation, there will be a question and answer session. To ask a question during the session, you will need to press star 1-1 on your telephone. You will then hear an automated message advising that your hand is raised. To withdraw your question, please press star 1-1 again. Please be advised that today's conference is being recorded. I would now like to turn the call over to Meredith Kaya, Senior Vice President, Investor Relations and Strategic Finance.
Meredith Kaya
Senior Vice President, Investor Relations and Strategic Finance
Please go ahead.
Unknown
Earnings Call Host
Good morning, and thank you for joining us to discuss the Pellis' fourth quarter and full year 2024 financial results.
You're reading a preview of the APLS Q4 2024 earnings call.
Free account.
Disclaimer